The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.

UAB is one of five centers named to host the first class of fellows in the Edmond J. Safra Fellowship in Movement Disorders.

Published in Faculty Excellence
A new study says that the cost of a medication may play a very important role in a patient’s perception of whether it works.
Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.

A UAB neuroscience student has received a summer fellowship from the Parkinson’s Disease Foundation.

Published in Student Experience
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Parkinson’s disease awareness is highlighted with official recognition from Alabama and the city of Birmingham in April.
Published in Service to Community
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
Published in Focus on Patient Care
Researchers at UAB show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
Published in Focus on Patient Care

The program supports and cultivates students interested in Parkinson’s related research projects.

Published in Student Experience

UAB Neurology adds to evidence that massive, second-wave reaction kills nerve cells.

UAB researchers partner with the Michael J. Fox Foundation on a new study of Parkinson’s disease risk factors, including a reduced sense of smell.

Parkinson’s researchers from UAB and UA may have unlocked the secrets of a gene that seems to have a protective effect against the disease.

Published in Focus on Patient Care
April 15, 2011

Standaert, David

Professor and chair of Neurology

Areas of expertise: Neurology, Parkinson’s disease, movement disorders, neurodegeneration

Published in Experts
Back to Top